Experimental browser for the Atmosphere
A new federal lawsuit challenges the FDA’s medically unnecessary restrictions on mifepristone, arguing they are politically motivated, not science-based—and a judge’s ruling could reshape access to abortion pills nationwide.
May 21, 2025, 3:44 PM
{
"text": "A new federal lawsuit challenges the FDA’s medically unnecessary restrictions on mifepristone, arguing they are politically motivated, not science-based—and a judge’s ruling could reshape access to abortion pills nationwide.",
"$type": "app.bsky.feed.post",
"embed": {
"$type": "app.bsky.embed.external",
"external": {
"uri": "https://msmagazine.com/2025/05/20/fda-abortion-pills-mifepristone-restrictions-safety/",
"thumb": {
"$type": "blob",
"ref": {
"$link": "bafkreibl7nkaexh6ext2ewnijt2k5sa5kjobz77h2e2n4gaiqxv2tptdmq"
},
"mimeType": "image/jpeg",
"size": 982973
},
"title": "Federal Court Considers Removing Medically Unnecessary FDA Restrictions on Abortion Pills",
"description": "The FDA maintains burdensome, medically unnecessary restrictions on mifepristone, which is used in combination with another medication—misoprostol—for early pregnancy termination. This combination of ..."
}
},
"langs": [
"en"
],
"createdAt": "2025-05-21T15:44:22.272Z"
}